Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Tectonic Therapeutic (TECX) Operating Expenses (2017 - 2026)

Tectonic Therapeutic (TECX) has 10 years of Operating Expenses data on record, last reported at $27.3 million in Q1 2026.

  • On a quarterly basis, Operating Expenses rose 49.2% to $27.3 million in Q1 2026 year-over-year; TTM through Mar 2026 was $93.0 million, a 46.87% increase, with the full-year FY2025 number at $84.0 million, up 44.85% from a year prior.
  • Operating Expenses reached $27.3 million in Q1 2026 per TECX's latest filing, up from $21.5 million in the prior quarter.
  • Over the last five years, Operating Expenses for TECX hit a ceiling of $29.4 million in Q1 2022 and a floor of $9.4 million in Q4 2023.
  • A 5-year average of $19.4 million and a median of $21.5 million in 2025 define the central range for Operating Expenses.
  • Peak YoY movement for Operating Expenses: plummeted 62.89% in 2023, then soared 95.53% in 2025.
  • Tracing TECX's Operating Expenses over 5 years: stood at $25.3 million in 2022, then tumbled by 62.89% to $9.4 million in 2023, then soared by 49.25% to $14.0 million in 2024, then skyrocketed by 53.78% to $21.5 million in 2025, then grew by 26.89% to $27.3 million in 2026.
  • Business Quant data shows Operating Expenses for TECX at $27.3 million in Q1 2026, $21.5 million in Q4 2025, and $21.9 million in Q3 2025.